首页 > 最新文献

BMC Women's Health最新文献

英文 中文
Evaluation of One Step Nucleic Acid Amplification for detection of lymph node metastases compared to histopathological ultrastaging in women with endometrial cancer: a protocol for a diagnostic accuracy study. 一步核酸扩增检测子宫内膜癌女性淋巴结转移的评价与组织病理学超转移:诊断准确性研究的方案。
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-09 DOI: 10.1186/s12905-025-03550-4
Jan Kostun, Alessandra Mescalchin, Martin Pešta, Robert Slunečko, Khaled M Ismail, Vendula Smoligová, Jiri Presl

Background: This is a multicentre, European, prospective trial evaluating the diagnostic accuracy of One Step Nucleic Acid Amplification (OSNA) compared to sentinel lymph nodes histopathological ultrastaging in endometrial cancer patients.

Methods: Centres with expertise in sentinel lymph node mapping in endometrial cancer patients in Europe will be invited to participate in the study. Participating units will be trained on the correct usage of the OSNA RD-210 analyser and nucleic acid amplification reagent kit LYNOAMP CK19 E for rapid detection of metastatic nodal involvement, based on the cytokeratin 19 (CK19) mRNA detection. Endometrial cancer patients ≥ 18 years listed for surgical treatment with sentinel lymph node mapping, with no history of other types of cancer and who provide a valid written consent will be considered potentially eligible for the study. However, they will only be enrolled if a successful sentinel lymph node mapping is retrieved. Each node will be processed according to the study protocol and assessed by both OSNA and ultrastaging.

Discussion: The accuracy of OSNA (index test) will be assessed against sentinel lymph node histopathological ultrastaging (reference test). This European study has the potential to be the largest study on the use of OSNA in endometrial cancer to date. OSNA could represent a modern diagnostic alternative to sentinel lymph node ultrastaging with the added benefits of standardisation and fast results.

Trial registration: The study was registered in the German Clinical Trial Register - Nr. DRKS00021520, registration date 25th of May 2020, URL of the trial registry record: https://drks.de/search/en/trial/DRKS00021520 .

背景:这是一项多中心、欧洲的前瞻性试验,评估一步核酸扩增(OSNA)与前哨淋巴结组织病理学超转移在子宫内膜癌患者中的诊断准确性。方法:将邀请欧洲在子宫内膜癌患者前哨淋巴结定位方面具有专业知识的中心参与研究。参与单位将接受培训,学习如何正确使用OSNA RD-210分析仪和核酸扩增试剂盒LYNOAMP CK19 E,基于细胞角蛋白19 (CK19) mRNA检测,快速检测转移淋巴结的受病灶。≥18岁的子宫内膜癌患者接受前哨淋巴结定位手术治疗,无其他类型癌症病史,并提供有效的书面同意,将被视为潜在的研究资格。然而,只有在成功的前哨淋巴结定位后,他们才会被招募。每个节点将根据研究方案进行处理,并由OSNA和超存储进行评估。讨论:OSNA(指数测试)的准确性将与前哨淋巴结组织病理学超调(参考测试)进行评估。这项欧洲研究有可能成为迄今为止在子宫内膜癌中使用OSNA的最大研究。OSNA可以作为前哨淋巴结超转移的现代诊断替代方案,具有标准化和快速结果的额外好处。试验注册:该研究已在德国临床试验注册中心注册-编号:DRKS00021520,注册日期为2020年5月25日,试验注册记录的URL: https://drks.de/search/en/trial/DRKS00021520。
{"title":"Evaluation of One Step Nucleic Acid Amplification for detection of lymph node metastases compared to histopathological ultrastaging in women with endometrial cancer: a protocol for a diagnostic accuracy study.","authors":"Jan Kostun, Alessandra Mescalchin, Martin Pešta, Robert Slunečko, Khaled M Ismail, Vendula Smoligová, Jiri Presl","doi":"10.1186/s12905-025-03550-4","DOIUrl":"10.1186/s12905-025-03550-4","url":null,"abstract":"<p><strong>Background: </strong>This is a multicentre, European, prospective trial evaluating the diagnostic accuracy of One Step Nucleic Acid Amplification (OSNA) compared to sentinel lymph nodes histopathological ultrastaging in endometrial cancer patients.</p><p><strong>Methods: </strong>Centres with expertise in sentinel lymph node mapping in endometrial cancer patients in Europe will be invited to participate in the study. Participating units will be trained on the correct usage of the OSNA RD-210 analyser and nucleic acid amplification reagent kit LYNOAMP CK19 E for rapid detection of metastatic nodal involvement, based on the cytokeratin 19 (CK19) mRNA detection. Endometrial cancer patients ≥ 18 years listed for surgical treatment with sentinel lymph node mapping, with no history of other types of cancer and who provide a valid written consent will be considered potentially eligible for the study. However, they will only be enrolled if a successful sentinel lymph node mapping is retrieved. Each node will be processed according to the study protocol and assessed by both OSNA and ultrastaging.</p><p><strong>Discussion: </strong>The accuracy of OSNA (index test) will be assessed against sentinel lymph node histopathological ultrastaging (reference test). This European study has the potential to be the largest study on the use of OSNA in endometrial cancer to date. OSNA could represent a modern diagnostic alternative to sentinel lymph node ultrastaging with the added benefits of standardisation and fast results.</p><p><strong>Trial registration: </strong>The study was registered in the German Clinical Trial Register - Nr. DRKS00021520, registration date 25th of May 2020, URL of the trial registry record: https://drks.de/search/en/trial/DRKS00021520 .</p>","PeriodicalId":9204,"journal":{"name":"BMC Women's Health","volume":"25 1","pages":"12"},"PeriodicalIF":2.4,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11715250/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142944887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors influencing endometrial receptivity in women with recurrent implantation failure. 反复着床失败妇女子宫内膜容受性的影响因素。
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-09 DOI: 10.1186/s12905-024-03531-z
Katarzyna Opuchlik, Katarzyna Pankiewicz, Piotr Pierzyński, Janusz Sierdziński, Elina Aleksejeva, Andres Salumets, Tadeusz Issat, Piotr Laudański

Background: Embryo implantation involves two key elements: a good quality embryo and receptive endometrium. Endometrial receptivity abnormalities are known as one of the possible causes of recurrent implantation failure (RIF), especially when the embryo is euploid. This study was aimed to evaluate the impact of age and other clinical factors on endometrial receptivity in women with RIF.

Methods: 68 women with RIF (defined as at least three unsuccessful transfers of good quality embryo of at least 1BB category of blastocysts) and 49 controls (women undergoing IVF treatment because of idiopathic infertility or male factor) were included to the study. After preparation of the endometrium by the hormone replacement therapy endometrial biopsies were taken from each patient and sequenced with beREADY test TAC targeting 67 biomarker genes for endometrial receptivity. Depending on the test result patients were classified into one of four different groups: pre-receptive (n = 16), early-receptive (n = 54), receptive (n = 44) and late-receptive (n = 3).

Results: In women with RIF pre-receptive endometrium has been detected substantially more often than in controls - 13 (19,1%) vs. 3 (6,1%) patients (p = 0,043). Early-receptive endometrium was diagnosed in the majority of patients with idiopathic infertility - 12 (66.7%) vs. 6 (33.3%) women (p = 0.042) and with polycystic ovary syndrome (PCOS) - 12 (70,6%) vs. 3 (17.7%) women (p = 0,0447). We found significant association between abnormal endometrial receptivity and patient's age and duration of infertility. Young women were diagnosed significantly more often as normal or late-receptive, whereas older women with longer history of infertility as early-receptive and pre-receptive.

Conclusions: In patients with RIF in comparison to other women undergoing IVF procedures, patient's age and infertility duration are the most important factors related to endometrial receptivity abnormalities, indicating that older women with a longer history of infertility may benefit the most from endometrial receptivity testing.

Trial registration: Not applicable.

背景:胚胎着床包括两个关键要素:高质量的胚胎和可接受的子宫内膜。子宫内膜容受性异常被认为是复发性着床失败(RIF)的可能原因之一,特别是当胚胎是整倍体时。本研究旨在评估年龄和其他临床因素对RIF妇女子宫内膜容受性的影响。方法:68名RIF患者(定义为至少3次成功移植至少1BB类囊胚的优质胚胎)和49名对照组(因特发性不育症或男性因素接受体外受精治疗的女性)纳入研究。通过激素替代疗法制备子宫内膜后,对每位患者进行子宫内膜活检,并对针对67个子宫内膜容受性生物标志物基因的beREADY测试TAC进行测序。根据测试结果,将患者分为四组:前接受性(n = 16)、早期接受性(n = 54)、接受性(n = 44)和晚期接受性(n = 3)。结果:RIF前受体子宫内膜在女性患者中的检出率明显高于对照组,13例(19.1%)vs 3例(6.1%)(p = 0.043)。大多数特发性不孕症患者(12例(66.7%)对6例(33.3%)女性(p = 0.042)和多囊卵巢综合征(PCOS)患者(12例(70.06%)对3例(17.7%)女性(p = 0,0447)诊断为早发性子宫内膜。我们发现子宫内膜容受性异常与患者的年龄和不孕持续时间有显著的相关性。年轻女性被诊断为正常或晚受精卵,而有较长不孕史的老年女性被诊断为早受精卵和前受精卵。结论:在RIF患者中,与其他接受体外受精的女性相比,患者的年龄和不孕持续时间是子宫内膜容受性异常的最重要因素,提示不孕史较长的老年女性可能从子宫内膜容受性检测中获益最多。试验注册:不适用。
{"title":"Factors influencing endometrial receptivity in women with recurrent implantation failure.","authors":"Katarzyna Opuchlik, Katarzyna Pankiewicz, Piotr Pierzyński, Janusz Sierdziński, Elina Aleksejeva, Andres Salumets, Tadeusz Issat, Piotr Laudański","doi":"10.1186/s12905-024-03531-z","DOIUrl":"10.1186/s12905-024-03531-z","url":null,"abstract":"<p><strong>Background: </strong>Embryo implantation involves two key elements: a good quality embryo and receptive endometrium. Endometrial receptivity abnormalities are known as one of the possible causes of recurrent implantation failure (RIF), especially when the embryo is euploid. This study was aimed to evaluate the impact of age and other clinical factors on endometrial receptivity in women with RIF.</p><p><strong>Methods: </strong>68 women with RIF (defined as at least three unsuccessful transfers of good quality embryo of at least 1BB category of blastocysts) and 49 controls (women undergoing IVF treatment because of idiopathic infertility or male factor) were included to the study. After preparation of the endometrium by the hormone replacement therapy endometrial biopsies were taken from each patient and sequenced with beREADY test TAC targeting 67 biomarker genes for endometrial receptivity. Depending on the test result patients were classified into one of four different groups: pre-receptive (n = 16), early-receptive (n = 54), receptive (n = 44) and late-receptive (n = 3).</p><p><strong>Results: </strong>In women with RIF pre-receptive endometrium has been detected substantially more often than in controls - 13 (19,1%) vs. 3 (6,1%) patients (p = 0,043). Early-receptive endometrium was diagnosed in the majority of patients with idiopathic infertility - 12 (66.7%) vs. 6 (33.3%) women (p = 0.042) and with polycystic ovary syndrome (PCOS) - 12 (70,6%) vs. 3 (17.7%) women (p = 0,0447). We found significant association between abnormal endometrial receptivity and patient's age and duration of infertility. Young women were diagnosed significantly more often as normal or late-receptive, whereas older women with longer history of infertility as early-receptive and pre-receptive.</p><p><strong>Conclusions: </strong>In patients with RIF in comparison to other women undergoing IVF procedures, patient's age and infertility duration are the most important factors related to endometrial receptivity abnormalities, indicating that older women with a longer history of infertility may benefit the most from endometrial receptivity testing.</p><p><strong>Trial registration: </strong>Not applicable.</p>","PeriodicalId":9204,"journal":{"name":"BMC Women's Health","volume":"25 1","pages":"15"},"PeriodicalIF":2.4,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11715555/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142944890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between the C-reactive protein-triglyceride-glucose index and endometriosis: a cross-sectional study using data from the national health and nutrition examination survey, 1996-2006. c反应蛋白-甘油三酯-葡萄糖指数与子宫内膜异位症之间的关系:1996-2006年全国健康和营养检查调查数据的横断面研究
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-09 DOI: 10.1186/s12905-024-03541-x
Yanan Ren, Ren Xu, Junqin Zhang, Ying Jin, Di Zhang, Yazhuo Wang, Luyang Su

Background: The C-reactive protein-triglyceride glucose index (CTI) is a promising new marker for evaluating the severity of inflammation. Endometriosis (EM) is a prevalent chronic inflammatory condition influenced by estrogen, primarily affecting women of reproductive age. However, no study has demonstrated an association between the CTI and EM.

Methods: This cross-sectional study sourced data from females 20-50 years of age from the National Health and Nutrition Examination Survey (NHANES) 1996-2006, and included those with self-reported diagnoses of EM and sufficient information to calculate the CTI, computed as 0.412 × ln (C-reactive protein [CRP]) + ln (triglycerides [mg/dL] × fasting plasma glucose [mg/dL]/2). Multivariate logistic regression, restricted cubic splines, and subgroup analyses were performed to examine the association between the CTI and EM.

Results: Data from 2235 women (175 [7.82%] with EM, 2060 [92.18%] without EM [controls]), were included: those with EM exhibited a tendency toward higher CTI (p = 0.005), and CTI was positively associated with the prevalence of EM (p = 0.011). In Model 1, a 1 mg/dL increment in CTI was associated with a 56% higher prevalence of EM (odds ratio [OR] 1.563 [95% confidence interval (CI) 1.295-1.885]; P < 0.001). This association in Model 2 (OR 1.609 [95% CI 1.334-1.941]; p < 0.001) and Model 3 (OR 1.565 [95% CI 1.246-1.966]; p < 0.001) remained significant. Notably, individuals in the uppermost remnant cholesterol tertile exhibited a notably higher prevalence of EM than those in the lowest tertile (OR 3.029, p = 0.051). Restricted cubic splines revealed a nonlinear positive association between CTI and the prevalence of EM. In addition, greater EM prevalence was observed with CTI in those > 40 years of age (OR 1.57 [95% CI 1.16-2.13]), body mass index ≥ 25 kg/m2 (OR 1.38 [95% CI 1.06-1.80]), smoking ≥ 100 cigarettes (OR 1.43 [95% CI 1.06-1.96]), married or living with partner (OR 1.41 [95% CI 1.09-1.85]), and oral contraceptive use (OR 1.35 [95% CI 1.07-1.69]).

Conclusions: CTI was positively associated with EM in women in the United States. Use of the CTI as an indicator of inflammation may provide new insights for the prevention and management of EM.

背景:c反应蛋白-甘油三酯葡萄糖指数(CTI)是一种很有前景的评估炎症严重程度的新标志物。子宫内膜异位症(EM)是一种受雌激素影响的常见慢性炎症,主要影响育龄妇女。方法:本横断研究的数据来自1996-2006年全国健康与营养调查(NHANES)中20-50岁的女性,包括那些自我报告诊断为EM的女性,并有足够的信息来计算CTI,计算结果为0.412 × ln (c -反应蛋白[CRP]) + ln(甘油三酯[mg/dL] ×空腹血糖[mg/dL]/2)。结果:纳入了2235名女性(EM患者175名[7.82%],未EM患者2060名[92.18%][对照组])的数据:EM患者的CTI倾向较高(p = 0.005), CTI与EM患病率呈正相关(p = 0.011)。在模型1中,CTI每增加1 mg/dL, EM患病率增加56%(优势比[OR] 1.563[95%可信区间(CI) 1.295-1.885];40岁(OR 1.57 [95% CI 1.16-2.13]),体重指数≥25 kg/m2 (OR 1.38 [95% CI 1.06-1.80]),吸烟≥100支(OR 1.43 [95% CI 1.06-1.96]),已婚或与伴侣同居(OR 1.41 [95% CI 1.09-1.85]),口服避孕药(OR 1.35 [95% CI 1.07-1.69])。结论:CTI与美国女性的EM呈正相关。使用CTI作为炎症指标可能为EM的预防和管理提供新的见解。
{"title":"Association between the C-reactive protein-triglyceride-glucose index and endometriosis: a cross-sectional study using data from the national health and nutrition examination survey, 1996-2006.","authors":"Yanan Ren, Ren Xu, Junqin Zhang, Ying Jin, Di Zhang, Yazhuo Wang, Luyang Su","doi":"10.1186/s12905-024-03541-x","DOIUrl":"10.1186/s12905-024-03541-x","url":null,"abstract":"<p><strong>Background: </strong>The C-reactive protein-triglyceride glucose index (CTI) is a promising new marker for evaluating the severity of inflammation. Endometriosis (EM) is a prevalent chronic inflammatory condition influenced by estrogen, primarily affecting women of reproductive age. However, no study has demonstrated an association between the CTI and EM.</p><p><strong>Methods: </strong>This cross-sectional study sourced data from females 20-50 years of age from the National Health and Nutrition Examination Survey (NHANES) 1996-2006, and included those with self-reported diagnoses of EM and sufficient information to calculate the CTI, computed as 0.412 × ln (C-reactive protein [CRP]) + ln (triglycerides [mg/dL] × fasting plasma glucose [mg/dL]/2). Multivariate logistic regression, restricted cubic splines, and subgroup analyses were performed to examine the association between the CTI and EM.</p><p><strong>Results: </strong>Data from 2235 women (175 [7.82%] with EM, 2060 [92.18%] without EM [controls]), were included: those with EM exhibited a tendency toward higher CTI (p = 0.005), and CTI was positively associated with the prevalence of EM (p = 0.011). In Model 1, a 1 mg/dL increment in CTI was associated with a 56% higher prevalence of EM (odds ratio [OR] 1.563 [95% confidence interval (CI) 1.295-1.885]; P < 0.001). This association in Model 2 (OR 1.609 [95% CI 1.334-1.941]; p < 0.001) and Model 3 (OR 1.565 [95% CI 1.246-1.966]; p < 0.001) remained significant. Notably, individuals in the uppermost remnant cholesterol tertile exhibited a notably higher prevalence of EM than those in the lowest tertile (OR 3.029, p = 0.051). Restricted cubic splines revealed a nonlinear positive association between CTI and the prevalence of EM. In addition, greater EM prevalence was observed with CTI in those > 40 years of age (OR 1.57 [95% CI 1.16-2.13]), body mass index ≥ 25 kg/m<sup>2</sup> (OR 1.38 [95% CI 1.06-1.80]), smoking ≥ 100 cigarettes (OR 1.43 [95% CI 1.06-1.96]), married or living with partner (OR 1.41 [95% CI 1.09-1.85]), and oral contraceptive use (OR 1.35 [95% CI 1.07-1.69]).</p><p><strong>Conclusions: </strong>CTI was positively associated with EM in women in the United States. Use of the CTI as an indicator of inflammation may provide new insights for the prevention and management of EM.</p>","PeriodicalId":9204,"journal":{"name":"BMC Women's Health","volume":"25 1","pages":"13"},"PeriodicalIF":2.4,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11715703/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142944881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Narratives of incarcerated women in a Prison in Malawi: a qualitative study. 马拉维监狱中被监禁妇女的叙述:一项定性研究。
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-09 DOI: 10.1186/s12905-025-03545-1
Ellen Samwiri Nkambule, Balwani Chingatichifwe Mbakaya

Background: In Malawi, women in prisons make up 2.7% of the total prison population. However, the experiences of women incarcerated are not well documented in the literature. We aim to describe the experiences of women incarcerated in a Malawian prison facility. We will concentrate on the qualitative findings that highlight the unique perspectives of these women, including those in which they are imprisoned alongside their children, as well as the larger implications for child welfare and prison policy.

Methods: A qualitative approach using descriptive study design was used to explore the experiences of incarcerated women in prisons in Malawi. In-depth interviews were conducted with seven incarcerated women (n = 7). The interviews followed a semi-structured interview guide, and the data were analyzed manually using thematic analysis.

Results: The following four themes emerged from the data: the burden of conviction, prison as a traumatic environment, health insecurity and perceptions regarding release from prison. Participants reported that being convicted caused significant psychosocial stress. The incarcerated women stated that they are subjected to inhumane and degrading treatment. The prison conditions are poor. The nutrition is inadequate for both incarcerated women and their children. Incarcerated women look forward to their release, citing that they have been transformed and are optimistic about their new lives. Prison living made them calmer and more patient. Others express concern that the stigma of incarceration will inhibit their ability to reconnect with the community upon release.

Conclusion: Understanding women's experiences in Malawian prisons can inform policy and improve standards of living for incarcerated women in Malawian prisons.

背景:在马拉维,监狱中的女性占监狱总人口的2.7%。然而,被监禁妇女的经历并没有在文献中得到很好的记录。我们的目的是描述被监禁在马拉维监狱设施的妇女的经历。我们将把重点放在定性调查结果上,这些调查结果突出了这些妇女的独特视角,包括她们与子女一起被监禁的情况,以及对儿童福利和监狱政策的更大影响。方法:采用描述性研究设计的定性方法来探讨马拉维监狱中被监禁妇女的经历。对7名被监禁妇女(n = 7)进行了深入访谈。访谈遵循半结构化访谈指南,并使用主题分析对数据进行手动分析。结果:从数据中产生了以下四个主题:定罪负担、监狱作为一个创伤性环境、健康不安全以及对出狱的看法。参与者报告说,被定罪造成了严重的心理压力。被监禁的妇女说,她们受到不人道和有辱人格的待遇。监狱条件很差。被监禁的妇女及其子女的营养不足。被监禁的女性期待她们的释放,理由是她们已经改变,并对她们的新生活持乐观态度。监狱生活使他们更平静,更有耐心。其他人则担心,监禁的耻辱会抑制他们获释后与社区重新联系的能力。结论:了解马拉维监狱中妇女的经历可以为政策提供信息,并改善马拉维监狱中被监禁妇女的生活水平。
{"title":"Narratives of incarcerated women in a Prison in Malawi: a qualitative study.","authors":"Ellen Samwiri Nkambule, Balwani Chingatichifwe Mbakaya","doi":"10.1186/s12905-025-03545-1","DOIUrl":"10.1186/s12905-025-03545-1","url":null,"abstract":"<p><strong>Background: </strong>In Malawi, women in prisons make up 2.7% of the total prison population. However, the experiences of women incarcerated are not well documented in the literature. We aim to describe the experiences of women incarcerated in a Malawian prison facility. We will concentrate on the qualitative findings that highlight the unique perspectives of these women, including those in which they are imprisoned alongside their children, as well as the larger implications for child welfare and prison policy.</p><p><strong>Methods: </strong>A qualitative approach using descriptive study design was used to explore the experiences of incarcerated women in prisons in Malawi. In-depth interviews were conducted with seven incarcerated women (n = 7). The interviews followed a semi-structured interview guide, and the data were analyzed manually using thematic analysis.</p><p><strong>Results: </strong>The following four themes emerged from the data: the burden of conviction, prison as a traumatic environment, health insecurity and perceptions regarding release from prison. Participants reported that being convicted caused significant psychosocial stress. The incarcerated women stated that they are subjected to inhumane and degrading treatment. The prison conditions are poor. The nutrition is inadequate for both incarcerated women and their children. Incarcerated women look forward to their release, citing that they have been transformed and are optimistic about their new lives. Prison living made them calmer and more patient. Others express concern that the stigma of incarceration will inhibit their ability to reconnect with the community upon release.</p><p><strong>Conclusion: </strong>Understanding women's experiences in Malawian prisons can inform policy and improve standards of living for incarcerated women in Malawian prisons.</p>","PeriodicalId":9204,"journal":{"name":"BMC Women's Health","volume":"25 1","pages":"14"},"PeriodicalIF":2.4,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11715022/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142944898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global, regional, and national burden of anxiety disorders during the perimenopause (1990-2021) and projections to 2035. 围绝经期焦虑症的全球、区域和国家负担(1990-2021年)以及到2035年的预测。
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-07 DOI: 10.1186/s12905-025-03547-z
Ying Zhang, Ting-Ting Hu, Yong-Ran Cheng, Zhi-Fen Zhang, Jun Su

Purpose: Perimenopause is associated with an increased risk of anxiety disorders, largely due to hormonal changes affecting the body's regulatory feedback mechanisms. This study aims to provide a comprehensive analysis of the global burden of anxiety disorders among perimenopausal women.

Methods: Data from the 2021 Global Burden of Disease (GBD) database were utilized to assess disability-adjusted life years associated with anxiety disorders linked to perimenopause. We calculated trends using the estimated average percent change, and future projections were made using the Bayesian age-period-cohort model to estimate disability-adjusted life year trends for anxiety disorders from 2022 to 2035.

Results: Between 1990 and 2021, the global age-standardized disability-adjusted life year rate for anxiety disorders among perimenopausal women increased from 625.51 (95% uncertainty interval: 429.1-891.09) to 677.15 (95% uncertainty interval: 469.45-952.72), indicating a rising trend with an estimated average percent change of 0.081 (95% confidence interval: 0.0043-0.143). Regional differences were noted, with anxiety disorder burdens varying across areas with different sociodemographic index levels. Projections suggest that by 2035, the global burden of anxiety disorders in perimenopausal women will rise to 1,180.43 per 100,000, a 40.67% increase compared with 2021 levels.

Conclusion: The burden of anxiety disorders during perimenopause is a growing global concern, with a significant increase anticipated in the coming years. Targeted prevention and intervention strategies are urgently needed to mitigate this rising burden and improve mental health outcomes during perimenopause.

目的:围绝经期与焦虑障碍的风险增加有关,主要是由于激素的变化影响了身体的调节反馈机制。本研究旨在对全球围绝经期妇女焦虑症负担进行全面分析。方法:使用2021年全球疾病负担(GBD)数据库的数据来评估与围绝经期焦虑症相关的残疾调整生命年。我们使用估计的平均百分比变化来计算趋势,并使用贝叶斯年龄-时期-队列模型进行未来预测,以估计2022年至2035年焦虑障碍的残疾调整生命年趋势。结果:1990年至2021年间,围绝经期妇女焦虑障碍的全球年龄标准化残疾调整生命年率从625.51(95%不确定区间:429.1-891.09)上升至677.15(95%不确定区间:469.45-952.72),呈上升趋势,估计平均百分比变化为0.081(95%可信区间:0.0043-0.143)。注意到地区差异,焦虑障碍负担在不同社会人口指数水平的地区有所不同。预测表明,到2035年,全球围绝经期妇女焦虑症负担将上升至每10万人中有1180.43人,比2021年的水平增加40.67%。结论:围绝经期焦虑症的负担日益受到全球关注,预计未来几年将显著增加。迫切需要有针对性的预防和干预策略来减轻这一日益增加的负担,并改善围绝经期的心理健康结果。
{"title":"Global, regional, and national burden of anxiety disorders during the perimenopause (1990-2021) and projections to 2035.","authors":"Ying Zhang, Ting-Ting Hu, Yong-Ran Cheng, Zhi-Fen Zhang, Jun Su","doi":"10.1186/s12905-025-03547-z","DOIUrl":"https://doi.org/10.1186/s12905-025-03547-z","url":null,"abstract":"<p><strong>Purpose: </strong>Perimenopause is associated with an increased risk of anxiety disorders, largely due to hormonal changes affecting the body's regulatory feedback mechanisms. This study aims to provide a comprehensive analysis of the global burden of anxiety disorders among perimenopausal women.</p><p><strong>Methods: </strong>Data from the 2021 Global Burden of Disease (GBD) database were utilized to assess disability-adjusted life years associated with anxiety disorders linked to perimenopause. We calculated trends using the estimated average percent change, and future projections were made using the Bayesian age-period-cohort model to estimate disability-adjusted life year trends for anxiety disorders from 2022 to 2035.</p><p><strong>Results: </strong>Between 1990 and 2021, the global age-standardized disability-adjusted life year rate for anxiety disorders among perimenopausal women increased from 625.51 (95% uncertainty interval: 429.1-891.09) to 677.15 (95% uncertainty interval: 469.45-952.72), indicating a rising trend with an estimated average percent change of 0.081 (95% confidence interval: 0.0043-0.143). Regional differences were noted, with anxiety disorder burdens varying across areas with different sociodemographic index levels. Projections suggest that by 2035, the global burden of anxiety disorders in perimenopausal women will rise to 1,180.43 per 100,000, a 40.67% increase compared with 2021 levels.</p><p><strong>Conclusion: </strong>The burden of anxiety disorders during perimenopause is a growing global concern, with a significant increase anticipated in the coming years. Targeted prevention and intervention strategies are urgently needed to mitigate this rising burden and improve mental health outcomes during perimenopause.</p>","PeriodicalId":9204,"journal":{"name":"BMC Women's Health","volume":"25 1","pages":"11"},"PeriodicalIF":2.4,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11706191/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142944893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of large uterine cystic adenomyosis outside the uterus after laparoscopic myomectomy: a case report and literature review. 腹腔镜子宫肌瘤切除术后子宫外大子宫囊性血团1例报告并文献复习。
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-07 DOI: 10.1186/s12905-024-03543-9
Wancheng Zhao, Chunmei Zhang

Background: Uterine cystic adenomyosis is a rare form of focal adenomyosis that is primarily located within the myometrium. In this case report, we present a unique case of adult uterine cystic adenomyosis found outside the uterus following laparoscopic myomectomy.

Case presentation: The patient was a 36-year-old Chinese woman who had previously undergone laparoscopic surgery at our hospital to remove a 4 cm diameter diameter uterine fibroid six years prior. She returned to our hospital due to excessive menstruation and intermittent right lower abdominal pain for one year. Pelvic computed tomography revealed an endometriotic cyst on the right posterior side of the uterus seemingly connected to the uterine cavity. During surgery, we successfully removed a large well-defined cyst filled with typical chocolate-like fluid located outside the uterus with its root deeply embedded in the myometrium. Following surgery, we administered gonadotropin-releasing hormone analogs for six cycles without any observed recurrence.

Conclusion: This study describes an unusual occurrence of large adult uterine cystic adenomyosis located outside the uterus after laparoscopic myomectomy, potentially supporting the theory that endometrial injury invagination may be responsible for this condition.

背景:子宫囊性血凝斑是一种罕见的局灶性血凝斑,主要位于子宫肌层内。在这个病例报告中,我们提出了一个独特的病例成人子宫囊性血屏障发现子宫外腹腔镜子宫肌瘤切除术。病例介绍:患者是一名36岁的中国女性,6年前曾在我院行腹腔镜手术切除直径4cm的子宫肌瘤。因月经过多,间歇性右下腹疼痛一年,再次入院。盆腔计算机断层扫描显示子宫右侧后侧有子宫内膜异位囊肿,似乎与子宫腔相连。在手术中,我们成功地切除了一个位于子宫外的大囊肿,囊肿内充满了典型的巧克力样液体,囊肿的根深埋在子宫肌层中。手术后,我们给予促性腺激素释放激素类似物6个周期,没有观察到任何复发。结论:本研究描述了腹腔镜子宫肌瘤切除术后发生的子宫外巨大的成人子宫囊性子宫腺肌症的罕见现象,潜在地支持子宫内膜损伤内陷可能是导致这种情况的理论。
{"title":"A case of large uterine cystic adenomyosis outside the uterus after laparoscopic myomectomy: a case report and literature review.","authors":"Wancheng Zhao, Chunmei Zhang","doi":"10.1186/s12905-024-03543-9","DOIUrl":"https://doi.org/10.1186/s12905-024-03543-9","url":null,"abstract":"<p><strong>Background: </strong>Uterine cystic adenomyosis is a rare form of focal adenomyosis that is primarily located within the myometrium. In this case report, we present a unique case of adult uterine cystic adenomyosis found outside the uterus following laparoscopic myomectomy.</p><p><strong>Case presentation: </strong>The patient was a 36-year-old Chinese woman who had previously undergone laparoscopic surgery at our hospital to remove a 4 cm diameter diameter uterine fibroid six years prior. She returned to our hospital due to excessive menstruation and intermittent right lower abdominal pain for one year. Pelvic computed tomography revealed an endometriotic cyst on the right posterior side of the uterus seemingly connected to the uterine cavity. During surgery, we successfully removed a large well-defined cyst filled with typical chocolate-like fluid located outside the uterus with its root deeply embedded in the myometrium. Following surgery, we administered gonadotropin-releasing hormone analogs for six cycles without any observed recurrence.</p><p><strong>Conclusion: </strong>This study describes an unusual occurrence of large adult uterine cystic adenomyosis located outside the uterus after laparoscopic myomectomy, potentially supporting the theory that endometrial injury invagination may be responsible for this condition.</p>","PeriodicalId":9204,"journal":{"name":"BMC Women's Health","volume":"25 1","pages":"8"},"PeriodicalIF":2.4,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11705667/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142944878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intergenerational transitions in age at menarche: insights from Chandauli district, Uttar Pradesh, India. 月经初潮年龄的代际变化:来自印度北方邦Chandauli地区的见解。
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-07 DOI: 10.1186/s12905-024-03462-9
Sumedha, Suman Singh, Praveen Kumar Pathak

Background: Menarche, a milestone in a woman's reproductive journey, is influenced by various factors such as lifestyle and dietary habits. Recent studies have corroborated this claim and prompted further investigation. This study explores the connection between menarche timing with lifestyle and dietary habits among three generations of women from the Sakaldiha block of Chandauli district and presents valuable insights into the role of diet and lifestyle in this crucial reproductive event.

Methods: The study is based on primary data collected using multistage stratified random sampling. A comparative analysis of the mean age at menarche across independent variables has been conducted using the one-way analysis of variance (ANOVA) technique. Additionally, a multiple regression model has been developed to investigate the association between menarcheal age and various dietary, lifestyle and socio-economic factors among 400 respondents.

Results: The average age of menarche for respondents was 14.29 years (95% CI: 14.12, 14.45), which has decreased by 1.66 years from 14.89 years (95% CI: 14.63, 15.15) in women over 40 years of age to 13.23 years (95% CI: 12.97, 13.49) in the < 20 years age group. The study additionally found that dietary and lifestyle factors had an impact on the age of menarche, with those who regularly consumed junk food, occasionally ate meat/fish or eggs, completely avoided curd or buttermilk and engaged in non-resting leisure activities experiencing an earlier onset of menarche.

Conclusion: The study shows that diet and lifestyle affect age at menarche, with current generations experiencing an earlier onset of menstruation. The effect of socioeconomic status remains inconclusive.

背景:月经初潮是女性生殖过程中的一个里程碑,受生活方式和饮食习惯等多种因素的影响。最近的研究证实了这一说法,并促使进一步调查。这项研究探讨了来自Chandauli地区Sakaldiha街区的三代女性的月经初潮时间与生活方式和饮食习惯之间的联系,并为饮食和生活方式在这一重要生殖事件中的作用提供了有价值的见解。方法:采用多阶段分层随机抽样的方法收集第一手资料。使用单因素方差分析(ANOVA)技术对月经初潮的平均年龄进行了比较分析。此外,还建立了一个多元回归模型来调查400名受访者的月经初潮年龄与各种饮食、生活方式和社会经济因素之间的关系。结果:受访者月经初潮的平均年龄为14.29岁(95% CI: 14.12, 14.45),从40岁以上女性的14.89岁(95% CI: 14.63, 15.15)下降到13.23岁(95% CI: 12.97, 13.49),减少了1.66岁。结论:研究表明饮食和生活方式影响月经初潮年龄,当代人经历月经初潮的早期发作。社会经济地位的影响仍然没有定论。
{"title":"Intergenerational transitions in age at menarche: insights from Chandauli district, Uttar Pradesh, India.","authors":"Sumedha, Suman Singh, Praveen Kumar Pathak","doi":"10.1186/s12905-024-03462-9","DOIUrl":"https://doi.org/10.1186/s12905-024-03462-9","url":null,"abstract":"<p><strong>Background: </strong>Menarche, a milestone in a woman's reproductive journey, is influenced by various factors such as lifestyle and dietary habits. Recent studies have corroborated this claim and prompted further investigation. This study explores the connection between menarche timing with lifestyle and dietary habits among three generations of women from the Sakaldiha block of Chandauli district and presents valuable insights into the role of diet and lifestyle in this crucial reproductive event.</p><p><strong>Methods: </strong>The study is based on primary data collected using multistage stratified random sampling. A comparative analysis of the mean age at menarche across independent variables has been conducted using the one-way analysis of variance (ANOVA) technique. Additionally, a multiple regression model has been developed to investigate the association between menarcheal age and various dietary, lifestyle and socio-economic factors among 400 respondents.</p><p><strong>Results: </strong>The average age of menarche for respondents was 14.29 years (95% CI: 14.12, 14.45), which has decreased by 1.66 years from 14.89 years (95% CI: 14.63, 15.15) in women over 40 years of age to 13.23 years (95% CI: 12.97, 13.49) in the < 20 years age group. The study additionally found that dietary and lifestyle factors had an impact on the age of menarche, with those who regularly consumed junk food, occasionally ate meat/fish or eggs, completely avoided curd or buttermilk and engaged in non-resting leisure activities experiencing an earlier onset of menarche.</p><p><strong>Conclusion: </strong>The study shows that diet and lifestyle affect age at menarche, with current generations experiencing an earlier onset of menstruation. The effect of socioeconomic status remains inconclusive.</p>","PeriodicalId":9204,"journal":{"name":"BMC Women's Health","volume":"25 1","pages":"9"},"PeriodicalIF":2.4,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11705782/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142944895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contraceptive experience and factors associated with desire for postpartum family planning among pregnant women of the nkongsamba health district, Littoral Region, Cameroon. 喀麦隆沿海地区nkongsamba保健区的孕妇的避孕经验和与产后计划生育愿望相关的因素。
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-07 DOI: 10.1186/s12905-025-03546-0
Atem Bethel Ajong, Martin Ndinakie Yakum, Fulbert Nkwele Mangala, Cavin Epie Bekolo, Valirie Ndip Agbor, Larissa Matcha Waffo, Bruno Kenfack

Background: The postpartum period remains a very important period during which contraceptive needs can be met and a significant reduction of maternal and foetal morbi-mortality achieved. This study aimed to evaluate past contraceptive experience and identify factors associated with the desire for postpartum family planning among women in late pregnancy.

Methods: We conducted a cross-sectional survey from September 2020 to December 2021 in four major health facilities of the Nkongsamba Health District, Cameroon, and consecutively included all pregnant women in late pregnancy, who came for antenatal follow-up in these health facilities. Data were collected using a semi-structured interviewer-administered questionnaire. Multivariable logistic regression was used to estimate adjusted odds ratios (AORs) for the factors associated with desire for postpartum family planning. Two-tailed p-values < 0.05 were considered statistically significant.

Results: Among the 1074 participants, 41.71% [95% CI: 38.78-44.70] reported a future desire for modern postpartum contraception. The self-reported prevalence of use of modern contraception in the past in the study population was 48.87% [95%CI: 45.86-51.88]. Only 17.64% [95%CI: 14.59-21.16] of women had adopted a modern contraceptive method other than the barrier methods in the past. Among pregnant women who had used modern contraception in the past, 11.50% [95%CI: 9.02-14.55] reported to have had their modern contraceptive experience with long-acting reversible contraceptives (LARCs). The prevalence of unintended pregnancy (current pregnancy) was 40.04% [37.15-43.00], with 11.55% being unwanted, and 28.49% mistimed. Compared to their respective counterparts, participants ≤ 30 years old (AOR = 0.71[0.52-0.99]), with monthly revenue below 100 thousand FCFA (AOR = 0.45[0.32-0.62]), who were single (AOR = 0.38[0.27-0.54]), had lower odds for desire of postpartum family planning. In contrast, women who were Christians (AOR = 2.13[1.27-3.58]), with a history of use of modern contraception before conception (AOR = 2.80[2.02-3.90]), and had a current unintended term pregnancy had higher odds of desiring postpartum contraception (AOR = 2.91[2.13-3.99]).

Conclusion: The desire for postpartum family planning is still low among pregnant women. This desire for postpartum family planning depends on sociodemographic factors and past contraceptive practices.

背景:产后时期仍然是一个非常重要的时期,在此期间,避孕需求可以得到满足,孕产妇和胎儿的发病率和死亡率显著降低。本研究旨在评估过去的避孕经验,并确定与怀孕后期妇女产后计划生育愿望相关的因素。方法:我们于2020年9月至2021年12月在喀麦隆Nkongsamba卫生区的四个主要卫生机构进行了横断面调查,并连续纳入了在这些卫生机构进行产前随访的所有孕晚期孕妇。数据收集采用半结构化访谈者管理的问卷。采用多变量logistic回归估计与产后计划生育意愿相关因素的调整优势比(AORs)。双尾p值结果:在1074名参与者中,41.71% [95% CI: 38.78-44.70]报告未来希望采用现代产后避孕。在研究人群中,自我报告过去使用现代避孕药具的患病率为48.87% [95%CI: 45.86-51.88]。只有17.64% [95%CI: 14.59 ~ 21.16]的妇女在过去使用过屏障避孕法以外的现代避孕方法。在既往使用现代避孕方法的孕妇中,11.50% [95%CI: 9.02-14.55]报告曾使用长效可逆避孕药(LARCs)进行现代避孕。意外妊娠(现孕)发生率为40.04%[37.15-43.00],其中11.55%为意外妊娠,28.49%为不合时宜妊娠。年龄≤30岁(AOR = 0.71[0.52-0.99])、月收入在10万FCFA以下(AOR = 0.45[0.32-0.62])、单身(AOR = 0.38[0.27-0.54])的女性产后计划生育意愿的比例较同龄女性低。相比之下,基督徒(AOR = 2.13[1.27-3.58])、孕前有现代避孕史(AOR = 2.80[2.02-3.90])、目前有意外妊娠的女性产后避孕意愿的比例更高(AOR = 2.91[2.13-3.99])。结论:孕妇对产后计划生育的意愿仍然较低。这种产后计划生育的愿望取决于社会人口因素和过去的避孕措施。
{"title":"Contraceptive experience and factors associated with desire for postpartum family planning among pregnant women of the nkongsamba health district, Littoral Region, Cameroon.","authors":"Atem Bethel Ajong, Martin Ndinakie Yakum, Fulbert Nkwele Mangala, Cavin Epie Bekolo, Valirie Ndip Agbor, Larissa Matcha Waffo, Bruno Kenfack","doi":"10.1186/s12905-025-03546-0","DOIUrl":"https://doi.org/10.1186/s12905-025-03546-0","url":null,"abstract":"<p><strong>Background: </strong>The postpartum period remains a very important period during which contraceptive needs can be met and a significant reduction of maternal and foetal morbi-mortality achieved. This study aimed to evaluate past contraceptive experience and identify factors associated with the desire for postpartum family planning among women in late pregnancy.</p><p><strong>Methods: </strong>We conducted a cross-sectional survey from September 2020 to December 2021 in four major health facilities of the Nkongsamba Health District, Cameroon, and consecutively included all pregnant women in late pregnancy, who came for antenatal follow-up in these health facilities. Data were collected using a semi-structured interviewer-administered questionnaire. Multivariable logistic regression was used to estimate adjusted odds ratios (AORs) for the factors associated with desire for postpartum family planning. Two-tailed p-values < 0.05 were considered statistically significant.</p><p><strong>Results: </strong>Among the 1074 participants, 41.71% [95% CI: 38.78-44.70] reported a future desire for modern postpartum contraception. The self-reported prevalence of use of modern contraception in the past in the study population was 48.87% [95%CI: 45.86-51.88]. Only 17.64% [95%CI: 14.59-21.16] of women had adopted a modern contraceptive method other than the barrier methods in the past. Among pregnant women who had used modern contraception in the past, 11.50% [95%CI: 9.02-14.55] reported to have had their modern contraceptive experience with long-acting reversible contraceptives (LARCs). The prevalence of unintended pregnancy (current pregnancy) was 40.04% [37.15-43.00], with 11.55% being unwanted, and 28.49% mistimed. Compared to their respective counterparts, participants ≤ 30 years old (AOR = 0.71[0.52-0.99]), with monthly revenue below 100 thousand FCFA (AOR = 0.45[0.32-0.62]), who were single (AOR = 0.38[0.27-0.54]), had lower odds for desire of postpartum family planning. In contrast, women who were Christians (AOR = 2.13[1.27-3.58]), with a history of use of modern contraception before conception (AOR = 2.80[2.02-3.90]), and had a current unintended term pregnancy had higher odds of desiring postpartum contraception (AOR = 2.91[2.13-3.99]).</p><p><strong>Conclusion: </strong>The desire for postpartum family planning is still low among pregnant women. This desire for postpartum family planning depends on sociodemographic factors and past contraceptive practices.</p>","PeriodicalId":9204,"journal":{"name":"BMC Women's Health","volume":"25 1","pages":"10"},"PeriodicalIF":2.4,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11706057/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142944882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness and tolerability of lactic acid vaginal gel compared to oral metronidazole in the treatment of acute symptomatic bacterial vaginosis: a multicenter, randomized-controlled, head-to-head pilot study. 乳酸阴道凝胶与口服甲硝唑治疗急性症状性细菌性阴道病的疗效和耐受性比较:一项多中心、随机对照、头对头的先导研究
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-06 DOI: 10.1186/s12905-024-03513-1
Fiona Tidbury, Grégory Brülhart, Gabriela Müller, Elena Pavicic, Susanna Weidlinger, Gerrit Eichner, Michael von Wolff, Petra Stute

Background: Bacterial vaginosis (BV) is a prevalent vaginal condition among reproductive-age women, characterized by off-white, thin vaginal discharge with a fishy odor. It increases susceptibility to sexually transmitted diseases (STDs) and pelvic inflammatory disease (PID). BV involves a shift in vaginal microbiota, with reduced lactobacilli and increased anaerobic bacteria. Standard treatment with oral metronidazole has been shown to have a limited long-term efficacy, possibly due to biofilm persistence. Alternative treatments, such as lactic acid vaginal gel, aim to restore vaginal pH and lactobacilli. This pilot study compares the efficacy and tolerability of lactic acid gel to standard oral metronidazole for acute BV treatment in non-pregnant women.

Methods: A total of 32 women with acute BV were recruited and assigned to either the treatment group (n = 16) where they applied a lactic acid vaginal gel for 12 days, or the control group (n = 16) which received 500 mg oral metronidazole twice daily for seven days. A number of objective and subjective parameters including the Amsel score, the Nugent score and a subjective symptom score were recorded at day 0, three weeks, three months, and six months after the study start.

Results: In the short-term, lactic acid vaginal gel showed inferior clinical (Amsel criteria) and microbiological (Nugent score) cure rates compared to metronidazole. However, it performed equally well regarding subjective symptom improvement and BV recurrence prevention after up to six months.

Conclusion: Lactic acid vaginal gel was generally very well tolerated and showed mixed but promising results as a stand-alone treatment for acute BV.

Trial registration number: NCT02042287 (22.01.2014).

背景:细菌性阴道病(细菌性阴道病)是育龄妇女中一种常见的阴道疾病,其特征是灰白色,阴道分泌物薄,有鱼腥味。它增加了对性传播疾病(std)和盆腔炎(PID)的易感性。细菌性阴道炎涉及阴道微生物群的变化,乳酸菌减少,厌氧菌增加。口服甲硝唑的标准治疗长期疗效有限,可能是由于生物膜的持久性。替代疗法,如乳酸阴道凝胶,旨在恢复阴道pH值和乳酸杆菌。本初步研究比较了乳酸凝胶与标准口服甲硝唑治疗非孕妇急性细菌性阴囊炎的疗效和耐受性。方法:共招募了32名急性BV女性,并将其分为治疗组(n = 16)和对照组(n = 16),治疗组(n = 16)使用乳酸阴道凝胶12天,对照组(n = 16)每天两次口服500 mg甲硝唑,持续7天。在研究开始后的第0天、3周、3个月和6个月记录一些客观和主观参数,包括Amsel评分、Nugent评分和主观症状评分。结果:与甲硝唑相比,乳酸阴道凝胶在短期内的临床(Amsel标准)和微生物(Nugent评分)治愈率较低。然而,在长达6个月的主观症状改善和BV复发预防方面,它同样表现良好。结论:乳酸阴道凝胶作为一种单独治疗急性细菌性阴道炎的药物,通常具有良好的耐受性,效果喜人。试验注册号:NCT02042287(22.01.2014)。
{"title":"Effectiveness and tolerability of lactic acid vaginal gel compared to oral metronidazole in the treatment of acute symptomatic bacterial vaginosis: a multicenter, randomized-controlled, head-to-head pilot study.","authors":"Fiona Tidbury, Grégory Brülhart, Gabriela Müller, Elena Pavicic, Susanna Weidlinger, Gerrit Eichner, Michael von Wolff, Petra Stute","doi":"10.1186/s12905-024-03513-1","DOIUrl":"https://doi.org/10.1186/s12905-024-03513-1","url":null,"abstract":"<p><strong>Background: </strong>Bacterial vaginosis (BV) is a prevalent vaginal condition among reproductive-age women, characterized by off-white, thin vaginal discharge with a fishy odor. It increases susceptibility to sexually transmitted diseases (STDs) and pelvic inflammatory disease (PID). BV involves a shift in vaginal microbiota, with reduced lactobacilli and increased anaerobic bacteria. Standard treatment with oral metronidazole has been shown to have a limited long-term efficacy, possibly due to biofilm persistence. Alternative treatments, such as lactic acid vaginal gel, aim to restore vaginal pH and lactobacilli. This pilot study compares the efficacy and tolerability of lactic acid gel to standard oral metronidazole for acute BV treatment in non-pregnant women.</p><p><strong>Methods: </strong>A total of 32 women with acute BV were recruited and assigned to either the treatment group (n = 16) where they applied a lactic acid vaginal gel for 12 days, or the control group (n = 16) which received 500 mg oral metronidazole twice daily for seven days. A number of objective and subjective parameters including the Amsel score, the Nugent score and a subjective symptom score were recorded at day 0, three weeks, three months, and six months after the study start.</p><p><strong>Results: </strong>In the short-term, lactic acid vaginal gel showed inferior clinical (Amsel criteria) and microbiological (Nugent score) cure rates compared to metronidazole. However, it performed equally well regarding subjective symptom improvement and BV recurrence prevention after up to six months.</p><p><strong>Conclusion: </strong>Lactic acid vaginal gel was generally very well tolerated and showed mixed but promising results as a stand-alone treatment for acute BV.</p><p><strong>Trial registration number: </strong>NCT02042287 (22.01.2014).</p>","PeriodicalId":9204,"journal":{"name":"BMC Women's Health","volume":"25 1","pages":"7"},"PeriodicalIF":2.4,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11702144/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142944885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ovarian adenomyoma: a case report. 卵巢腺肌瘤1例。
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-06 DOI: 10.1186/s12905-024-03533-x
Weilong Liu, Tongtong Yao, Haiyan Wang, Wenjing Yu, Hongtang Shi, Jiwei Guo, Zhiqiang Liu

Introduction: Ovarian adenomyoma is a rare gynecological tumor with a high misdiagnosis rate, leading many patients to undergo unnecessary surgeries that may affect fertility. Menstrual abdominal pain is the most common symptom, and auxiliary examinations often cannot clarify its nature. It often relies on intraoperative diagnosis, and surgical resection can achieve good therapeutic effects.

Case presentation: A 50-year-old woman presented with lower abdominal pain during her menstrual period for the past two months. She had a previous medical history of uterine adenomyomectomy, ovarian cystectomy, and a cesarean section. Ultrasound revealed a 5.7 × 3.8 × 4.3 cm mass on the posterior wall of the uterus, a 9.9 × 5.6 × 8.2 cm hypoechoic mass in the right posterior part of the uterus, and a 2.8 × 2.2 × 2.7 cm anechoic mass in the left ovary. CA125 (Carbohydrate antigen 125) 191.80U/ml (0-30). MRI (magnetic resonance imaging) imaging confirmed a 7.9 × 6.2 × 7.2 cm fibroid on the right posterior wall of the uterus. Consider partial degeneration of multiple uterine fibroids and benign cystic degeneration in the lower left abdomen. Surgical resection was performed smoothly, and the diagnosis was confirmed by postoperative pathology.

Conclusion: Ovarian adenomyoma is a rare benign gynecologic tumour with a high rate of misdiagnosis. When a patient presents with recent lower abdominal pain or dysmenorrhea, a history of endometriosis or myomectomy, and MRI findings showing irregular bleeding patterns in a pelvic mass, the possibility of extrauterine adenomyosis should be considered. Minimally invasive treatment options, such as single-port laparoscopy or vaginal dissection, may offer advantages, but caution should be exercised due to the potential for malignant tumors. Preserving fertility is something worth exploring. We hope to provide warnings to more gynaecologists and reduce misdiagnosis and unnecessary treatment.

卵巢腺肌瘤是一种罕见的妇科肿瘤,误诊率高,导致许多患者进行不必要的手术,可能影响生育能力。经期腹痛是最常见的症状,辅助检查往往不能明确其性质。它往往依赖于术中诊断,手术切除可取得良好的治疗效果。病例介绍:一名50岁的女性,在过去两个月的月经期间出现下腹部疼痛。既往有子宫腺肌瘤切除术、卵巢囊肿切除术及剖宫产手术史。超声示子宫后壁5.7 × 3.8 × 4.3 cm肿块,右侧子宫后壁9.9 × 5.6 × 8.2 cm低回声肿块,左侧卵巢2.8 × 2.2 × 2.7 cm无回声肿块。CA125(碳水化合物抗原125)191.80U/ml(0-30)。MRI(磁共振成像)成像证实子宫右后壁有一个7.9 × 6.2 × 7.2 cm的肌瘤。考虑多发性子宫肌瘤部分变性和左下腹良性囊性变性。手术切除顺利,术后病理证实诊断。结论:卵巢腺肌瘤是一种罕见的妇科良性肿瘤,误诊率高。当患者近期出现下腹痛或痛经,有子宫内膜异位症或子宫肌瘤切除术史,且MRI显示盆腔肿块出血不规则时,应考虑宫外bbb的可能性。微创治疗选择,如单孔腹腔镜或阴道解剖,可能提供优势,但应谨慎,因为潜在的恶性肿瘤。保持生育能力是一件值得探索的事情。我们希望为更多的妇科医生提供警示,减少误诊和不必要的治疗。
{"title":"Ovarian adenomyoma: a case report.","authors":"Weilong Liu, Tongtong Yao, Haiyan Wang, Wenjing Yu, Hongtang Shi, Jiwei Guo, Zhiqiang Liu","doi":"10.1186/s12905-024-03533-x","DOIUrl":"https://doi.org/10.1186/s12905-024-03533-x","url":null,"abstract":"<p><strong>Introduction: </strong>Ovarian adenomyoma is a rare gynecological tumor with a high misdiagnosis rate, leading many patients to undergo unnecessary surgeries that may affect fertility. Menstrual abdominal pain is the most common symptom, and auxiliary examinations often cannot clarify its nature. It often relies on intraoperative diagnosis, and surgical resection can achieve good therapeutic effects.</p><p><strong>Case presentation: </strong>A 50-year-old woman presented with lower abdominal pain during her menstrual period for the past two months. She had a previous medical history of uterine adenomyomectomy, ovarian cystectomy, and a cesarean section. Ultrasound revealed a 5.7 × 3.8 × 4.3 cm mass on the posterior wall of the uterus, a 9.9 × 5.6 × 8.2 cm hypoechoic mass in the right posterior part of the uterus, and a 2.8 × 2.2 × 2.7 cm anechoic mass in the left ovary. CA125 (Carbohydrate antigen 125) 191.80U/ml (0-30). MRI (magnetic resonance imaging) imaging confirmed a 7.9 × 6.2 × 7.2 cm fibroid on the right posterior wall of the uterus. Consider partial degeneration of multiple uterine fibroids and benign cystic degeneration in the lower left abdomen. Surgical resection was performed smoothly, and the diagnosis was confirmed by postoperative pathology.</p><p><strong>Conclusion: </strong>Ovarian adenomyoma is a rare benign gynecologic tumour with a high rate of misdiagnosis. When a patient presents with recent lower abdominal pain or dysmenorrhea, a history of endometriosis or myomectomy, and MRI findings showing irregular bleeding patterns in a pelvic mass, the possibility of extrauterine adenomyosis should be considered. Minimally invasive treatment options, such as single-port laparoscopy or vaginal dissection, may offer advantages, but caution should be exercised due to the potential for malignant tumors. Preserving fertility is something worth exploring. We hope to provide warnings to more gynaecologists and reduce misdiagnosis and unnecessary treatment.</p>","PeriodicalId":9204,"journal":{"name":"BMC Women's Health","volume":"25 1","pages":"6"},"PeriodicalIF":2.4,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142930561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMC Women's Health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1